A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer
Clinical trial NCT05980481 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05980481
- Sponsor
- RemeGen Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-04
- Primary completion
- 2025-07-10
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.